A carboxamide-substituted benzhydryl amine, CBA-1, functions as a KDM3A/3B inhibitor (typically inhibiting KDM3A), causes increased levels of H3K9me2, inhibits Wnt targets (Axin2, c-Myc, and Cyclin B1), and prevents colorectal cancer cell proliferation [122]. Here, KDM3A is linked to colorectal cancer.